StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Northland Capital Markets Downgrades Edwards Lifesciences (EW) to Market Perform (Earlier)
April 5, 2016 10:27 AM
Northland Capital Markets downgraded Edwards Lifesciences (NYSE: EW) from Outperform to Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Next Articles
Stifel Raises Price Target on Edwards Lifesciences (EW) to $117; Reiterates Buy
April 4, 2016 10:33 AM
Edwards Lifesciences (EW) Raising Estimates, PT on Better Than Expected Sapien 3 Data - Leerink Partners
April 4, 2016 7:50 AM
BTIG Upgrades Edwards Lifesciences (EW) to Buy
April 4, 2016 7:35 AM
Wall Street pulls back after recent rally
April 4, 2016 7:24 AM
Edwards Lifesciences (EW) PT Raised to $98 at Credit Suisse Following Sapien Data
April 4, 2016 7:21 AM
Edwards Lifesciences (EW) PT Raised to at Jefferies Following PARTNER II Sapien 3 Data
April 4, 2016 6:45 AM
Edwards Lifesciences' (EW) SAPIEN XT PARTNER II Trial Met Primary Endpoint
April 3, 2016 12:20 PM
